Combinatorial Targeting of Leukemia and Stromal Cells Overcomes Fms-like Tyrosine Kinase 3 (FLT3) Inhibitor Resistance in Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Bhattacharya, Seemana [1 ,2 ]
Mu, Hong [1 ,2 ]
Piya, Sujan [1 ,2 ]
Zhang, Weiguo [1 ,2 ]
McQueen, Teresa [1 ,2 ]
Paradiso, Linda [3 ]
Oberkovitz, Galia [4 ]
Benami, Eyal [4 ]
Andreeff, Michael [1 ,2 ]
Borthakur, Gautam [1 ,2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Houston, TX 77030 USA
[3] Strategia Therapeut Inc, 28420 Hardy Toll Rd,Suite 110, Spring, TX USA
[4] BioLineRx Ltd, Modiin Technol Pk 2,HaMaayan St, Modiin, Israel
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷
关键词：
AML; FLT3-ITD; dual MEK1-FLT3 inhibitor; peptidic CXCR4-antagonist; leukemia-stroma interactions;
D O I：
10.1016/j.clml.2017.07.049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-033
引用
收藏
页码：S273 / S273
页数：1
相关论文
共 50 条
  • [11] Activating Mutations of the FMS-Like Tyrosine Kinase-3 (FLT3) At Complete Response and Relapse in Patients with Acute Myeloid Leukemia
    Nazha, Aziz
    Cortes, Jorge E.
    Faderl, Stefan
    Pierce, Sherry
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Ferrajoli, Alessandra
    Kadia, Tapan
    Borthakur, Gautam
    Luthra, Rajyalakshmi
    Kantarjian, Hagop M.
    Ravandi, Farhad
    BLOOD, 2011, 118 (21) : 1518 - 1518
  • [12] Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy
    Zhang, Weiguo
    Yu, Guopan
    Zhang, Hongying
    Basyal, Mahesh
    Ly, Charlie
    Yuan, Bin
    Ruvolo, Vivian
    Piya, Sujan
    Bhattacharya, Seemana
    Zhang, Qi
    Borthakur, Gautam
    Battula, Venkata L.
    Konopleva, Marina
    Rice, William G.
    Andreeff, Michael
    HAEMATOLOGICA, 2023, 108 (06) : 1500 - 1514
  • [13] FMS-Like Tyrosine Kinase 3 Inhibitors for the Treatment of Acute Myeloid Leukemia
    Novatcheva, Elli D.
    Anouty, Yasmine
    Saunders, Ila
    Mangan, James K.
    Goodman, Aaron M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (03): : E161 - E184
  • [14] FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia
    Parcells, Bertrand W.
    Ikeda, Alan K.
    Simms-Waldrip, Tiffany
    Moore, Theodore B.
    Sakamoto, Kathleen M.
    STEM CELLS, 2006, 24 (05) : 1174 - 1184
  • [15] Identification of potential lead compound from Thuja occidentalis as an inhibitor of FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia through virtual screening
    Swetha, S.
    Manivannan, Hema Priya
    Francis, Arul Prakash
    Veeraraghavan, Vishnu Priya
    Gayathri, R.
    Sankaran, Kavitha
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2024, 61 (08): : 472 - 484
  • [16] Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
    Koo, Bon-Kwan
    Choi, Eun-Ji
    Moon, Ju Hyun
    Kim, Ji Yun
    Park, Hyunkyung
    Park, Han-Seung
    Choi, Yunsuk
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Choi, Eun Kyung
    Kim, Eunji
    Lee, Je-Hwan
    Hur, Eun-Hye
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [17] Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia
    Pemmaraju, Naveen
    Kantarjian, Hagop
    Andreeff, Michael
    Cortes, Jorge
    Ravandi, Farhad
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (07) : 943 - 954
  • [18] A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia
    Sellmer, Andreas
    Pilsl, Bernadette
    Beyer, Mandy
    Pongratz, Herwig
    Wirth, Lukas
    Elz, Sigurd
    Dove, Stefan
    Henninger, Sven Julian
    Spiekermann, Karsten
    Polzer, Harald
    Klaeger, Susan
    Kuster, Bernhard
    Boehmer, Frank D.
    Fiebig, Heinz-Herbert
    Kraemer, Oliver H.
    Mahboobi, Siavosh
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 193
  • [19] FLT3 Kinase Inhibitor TTT-3002 Overcomes Both Activating and Drug Resistance Mutations in FLT3 in Acute Myeloid Leukemia
    Ma, Hayley S.
    Bao Nguyen
    Duffield, Amy S.
    Li, Li
    Galanis, Allison
    Williams, Allen B.
    Brown, Patrick A.
    Levis, Mark J.
    Leahy, Daniel J.
    Small, Donald
    CANCER RESEARCH, 2014, 74 (18) : 5206 - 5217
  • [20] Selective cytotoxic mechanism of GTP-14564, a novel tyrosine kinase inhibitor in leukemia cells expressing a constitutively active Fms-like tyrosine kinase 3 (FLT3)
    Murata, K
    Kumagai, H
    Kawashima, T
    Tamitsu, K
    Irie, M
    Nakajima, H
    Suzu, S
    Shibuya, M
    Kamihira, S
    Nosaka, T
    Asano, S
    Kitamura, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) : 32892 - 32898
12345